Ангионорм®
Producer: CJSC Pharmfirma Soteks Russia
Code of automatic telephone exchange: C10AX
Release form: Firm dosage forms. Tablets.
General characteristics. Structure:
1 tablet, coated, contains 0,1 g of extract of the dry, received from mix medicinal vegetable raw materials – fruits of a hawthorn (Crataegi), glycyrrhiza roots (Glycyrrhiza glabra L.), seeds of a horse-chestnut ordinary (Aesculus hippocastanum L.), hips (Rozae).
Description: tablets of a biconvex form, coated yellow color.
Pharmacological properties:
Ангионорм® has the expressed anti-aggregation, antithrombocytic activity, angioprotektorny and antiinflammatory properties, has the venotoniziruyushchy and improving microcirculation effect, activates diuretic function of kidneys. Ангионорм® exerts impact on the general condition of an organism (increases physical protective activity and moderate analgetic effect).
Indications to use:
As a part of complex therapy of the diseases which are followed by vascular disorders, such as:
- increase in aggregation of thrombocytes (fibrinferment, thromboembolism);
- disturbance of permeability of capillaries and microcirculation (fibrinferment of capillaries);
- disturbances of venous blood circulation (varicosity, postrombotichesky syndrome, thrombophlebitises).
Route of administration and doses:
Ангионорм® accept inside on 1 tablet 3 times a day in 40 minutes after food. Duration of a course of treatment is up to 3 weeks. Increase in a single dose of Angionorma® up to 2 tablets 3 times a day in case of good tolerance is possible.
Side effects:
Allergic reactions, dispepsichesky frustration.
Interaction with other medicines:
Use of Angionorma® can be combined with other medicines: hypolipidemic, antiinflammatory, anesthetics, antibiotics, anticoagulants of direct and indirect action.
Contraindications:
Individual intolerance to drug components, the period of pregnancy and a lactation, a serious chronic illness of a liver, kidneys, digestive tract with disturbance of their function, children's age, pregnancy.
Overdose:
At prolonged use of Angionorma® in the doses exceeding the recommended daily medical dose strengthening of degree of manifestation of side effects is possible.
Issue conditions:
Without recipe
Packaging:
Tablets on 0,1 g, coated. On 30 tablets in a case from polymeric materials.